To date, hematopoietic development of human embryonic stem cells (hESCs) has been limited to cell lines cultured in the presence of either mouse embryonic fibroblasts (MEF) or MEF-conditioned media (MEF-CM). Anonymous xeno-factors from MEFs or MEF-CM complicate studies of hESC selfrenewal, and also raise concerns for the potential clinical applications of generating primitive hematopoietic cells from hESC lines maintained under these ambiguous conditions. Here, we demonstrate that hESCs can be cultured over 30 passages in defined conditions in the absence of MEF or MEF-CM using only serum replacement (SR) media and high concentrations of bFGF (SRbFGF). Similar to hESCs cultured in MEF-CM, hESCs cultured in SR-bFGF sustained characteristics of undifferentiated hESCs, proliferative potential, normal karyotype, in vitro and in vivo three germ layer specification, and gave rise to hemogenic-endothelial precursors required for subsequent primitive hematopoietic development. Our report demonstrates that anonymous factors produced by feeder cells are not necessary for hESC maintenance and subsequent hematopoietic specification, thereby providing a defined system for studies of hESC self renewal and hESC-derived hematopoiesis.
Introduction
Human ESC lines have been derived from the inner cell mass of human embryos by co-culture on either mouse or human embryonic feeder layers 1, 2 . To better define the conditions to propagate and differentiate hESC lines, Xu et al maintained hESCs in feeder-free conditions by feeding them with mouse embryonic fibroblasts (MEF)-conditioned media (MEF-CM) 3 . However, significant variations in the production of MEF and harvesting of MEF-CM have hampered reproducibility of these conditions to culture hESC stably 4 . Moreover, several unknown substances and combinations of factors contained in MEF-CM 5 further complicate fundamental studies of hESC self-renewal, impact future studies in defining factors that specify lineage maturation, and also become a concern for future clinical applications. Although hESCs have been documented to be capable of hematopoietic specification, maintenance of these hESCs required either MEF or MEF-CM [6] [7] [8] [9] [10] [11] [12] [13] [14] . In this report, we demonstrate that anonymous factors produced by feeder cells are not necessary for hESC maintenance and subsequent hematopoietic development, thereby providing a more defined system for further characterization of hESC self-renewal and lineage maturation.
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Materials and Methods
hESC culture and hEB formation. The hESC lines H9 and H1 1 cultured in MEF-CM 3, 7 were passed into either MEF-CM or serum replacement (SR) media containing high concentration of bFGF (SRbFGF). MEF-CM was collected as previously described 3, 7 and contained 12ng/mL of basic fibroblast growth factor (bFGF). SR-bFGF media consisted of 80% Knockout Dulbecco's modified Eagle medium (KO-DMEM, Gibco, Burlington, Canada), 20% serum replacement (SR), 24-36ng/mL bFGF (variants among batches), 1% nonessential amino acids, 1mM L-glutamine (all from Gibco, Burlington, Canada), and 0.1mM -mercaptoethanol (Sigma, Oakville, Canada). Maintenance of hESC lines was performed as previously described 3, 7 . In brief, hESC colonies were dissociated with collagenase IV (Gibco, Burlington, Canada) for 5 min and passed every 6-7 days. Occasionally, hESC colonies maintained either in MEF-CM or SR-bFGF was physically dissociated during passaging in order to reduce the numbers of fibroblast-like cells. The effect of bFGF on maintenance of hESC was determined by use of bFGF neutralization antibody (Abcam Inc. Cambridge, MA) 15 .
Formation of human embryoid bodies (hEBs), and preparation of single cells from hESCs and hEBs were performed as previously described 7 .
Immunocytochemical and histochemical staining of Oct4 and alkaline phosphatase (AP).
Cultured hESCs were fixed in the culture plates with 10% buffered formalin. Permeabilized hESCs were incubated for 30 min with 3 µg/ml either primary goat anti-Oct4 antibody (Santa Cruz, CA) or normal goat IgG isotype (Sigma, Saint Louis, Missouri) or antibody diluent alone, and visualized with Alexa Fluor 488 conjugated donkey anti-goat IgG secondary antibody (1:400, Molecular Probes, Eugene, OR). AP activity staining was then performed as previously described 7 with "Vector Red" substrate (Vector Laboratories, Burlingame, CA), and followed by DAPI counterstaining. The cells were examined with an Olympus fluorescent microscope. min at 4°C, the cells were washed twice and re-suspended in PBS containing 3% FBS, and finally stained with 7-aminoactinomycin D (7-AAD) viability dye (Immunotech) at 4µL/200µL for 15 min at room temperature. Live cells identified by 7-AAD exclusion were analyzed for surface marker expression using FACSCalibur (BDIS) and Cell Quest software (BDIS). Cell surface expression of SSEA-4 was determined as previously described 3, 7 .
Cell proliferation and karyotype of hESCs. Cell proliferation was determined as previously described 3, 7 . London Health Sciences Centre, Cytogenetics Laboratory, London, Ontario, Canada performed karyotype analysis.
Characterization of hESC-derived hemogenic precursors and hematopoietic cells.
CD45 neg PFV (CD45 negative, PECAM-1+, Flk1+ and VE-Cadherin+) hemogenic precursors and CD45+ hematopoietic cells derived from hESCs were characterized as previously described 9 .
Colony-forming unit (CFU) assays and Wright-Giemsa staining. Human clonogenic progenitor assays were performed by plating hESC derivatives (1x10 4 cells) into methylcellulose H4230 (Stem Cell Technologies, Vancouver, BC, Canada) supplemented with the following human recombinant growth factors: 50 ng/mL stem cell factor (Amgen Inc., Thousand Oaks, CA), 3 U/mL erythropoietin (Amgen Inc.), 10 ng/mL granulocyte monocyte colony-stimulating factor (Novartis, Dorval, QC, Canada), and 10 ng/mL IL-3 (R&D, Minneapolis, MN). After incubation for 10 to 14 days at 37°C and 5% CO2 in a humidified atmosphere, colony counts were performed based on standard morphological characteristics. Isolation of the cells from individual colonies, cytospin preparation and Wright-Giemsa staining were performed as previously described 7 .
Quantitative Real Time PCR (Q-PCR).
Total RNA was extracted and reverse-transcribed as described previously 8 
Statistical analysis.
Results were expressed as means ± SEM. Statistical significance was determined using an unpaired Student t test. Results were considered significant when P<0.05.
Results

SR-bFGF is capable of maintaining undifferentiated hESCs
To determine whether established hESCs could be grown in the absence of factors produced by feeders, we passed the hESC line H9 previously cultured in MEF-CM for 35 passages into either MEF-CM or defined SR-bFGF media conditions that was never directly or indirectly in contact with MEFs. In side-by-side comparisons with the same passage of hESCs cultured in MEF-CM, hESC cultured in SR-bFGF possessed similar properties. Using hESCs maintained in MEF-CM as our standard, undifferentiated colonies cultured in SR-bFGF had similar morphology, activity of alkaline phosphatase (AP) (Fig 1a) and expression of Oct4 17 (Fig 1b) . Flow cytometry analysis showed that SR-bFGF-maintained hESCs had comparable levels of Oct4, SSEA4, Tra-1-60 and Tra-1-81 expression (Fig. 1c) . The hESCs cultured in SR-bFGF also showed identical proliferation capacity to those cultured in MEF-CM (Fig. 1d ) and normal karyotype (Fig. 1e) . To assure the support of hESC growth using defined SR-FGF conditions was not restricted to one cell line alone, another hESC lin, H1 1 , was also maintained in an undifferentiated state in SR-bFGF over 8 passages (Fig. 2a and c) .
To examine which components of SR-bFGF conditions were crucial to hESC maintenance in an colonies were unable to attach to the plate, resulting in cell death after one passage (7 days). The role of bFGF in hESC maintenance was further examined by use of a neutralizing antibody specific to bFGF. Addition of the bFGF-neutralizing antibody to the MEF-CM media induced both H1 and H9 hESC differentiation and loss of hESC colony maintenance ( Fig. 2e and f) , suggesting that bFGF is an essential factor released by MEFs to support hESC lines. Collectively, these experiments indicate that the combination of SR media, high concentrations of bFGF, and matrigel or laminin are crucial for the maintenance of hESCs. In addition, these comparative analyses underscore the importance of long-term culture to define robust conditions for hESCs maintenance since hESCs seemingly possess autonomous survival responsiveness over limited (4-7 days) short-term culture. 
Human ESCs cultured in SR-bFGF are capable of characteristic hematopoietic development
The ability to form embryoid bodies (EBs), and subsequently undergo differentiation, is an important measure of the overall quality of hESC lines 7, 8 . To determine whether SR-bFGFmaintained hESCs are capable of EB development and differentiation as previously documented for hESCs cultured in MEF-CM 7, 8 , hESCs were allowed to aggregate into EBs 7 . Compared with EBs formed from MEF-CM-cultured hESCs, SR-bFGF-cultured hESCs produced similar number and size of EBs (Fig. 3a) .
To further examine whether SR-bFGF-cultured hESCs are capable of hematopoietic lineage specification, EBs were treated with a combination of hematopoietic cytokines (SCF, Flt3 Ligand, IL-3, IL-6, G-CSF) and the ventral mesoderm inducer bone morphogenetic protein-4 (BMP-4) to specify hematopoietic lineage differentiation 7, 8 . SR-bFGF-cultured hESCs followed a similar spatial and temporal hematopoietic developmental pattern to MEF-CM cultured hESCs. Similar numbers of CD45 neg PFV hemogenic precursors 9 were derived after 10 days of EB development from either MEF-CM or SR-bFGF-cultured hESCs in the presence of hematopoietic cytokines and BMP-4 (Fig   3b) . Development of hEBs for 22 days from either MEF-CM or SR-bFGF-cultured hESCs gave rise up to 74% of hematopoietic cells expressing pan-leukocyte marker CD45+ (Fig. 3c) , with similar primitive CD34+ hematopoietic cell composition (49732±15354 vs. 37648±26625, Fig. 3c ).
Consistent with our previous report 7 , hematopoietic cells generated from SR-bFGF-cultured hESCs contained similar hematopoietic progenitor capacity determined by the hematopoietic colony forming unit (CFU) assay 18 (Fig. 3d) . Hematopoietic colony types included erythyroid, macrophage, granulocyte and granulocyte-macrophage progenitors (Fig.4a-d) . Wright Giemsa staining of cytospin preparations of cell isolated from individual erythroid colonies showed mature enucleated erythrocytes and immature erythrocytes (Fig. 4e) , whereas cells from monocyte progenitors showed monocytic morphology (Fig. 4f) , and mature neutrophils and eosinophils from granulocytic progenitors (Fig. 4g) . Further analysis by flow cytometry of cells from individual erythroid colonies demonstrated expression of glycophorin A, and absence of CD45, whereas myelomonocytic markers CD33 and CD13 were absent (Fig. 4h,i) . In contrast, the cells comprising granulocyte colonies were stained negative for glycophorin A, but positive for CD45, myeloid markers CD33 and CD13 (Fig.   4j,k) . 
SR-bFGF-cultured hESCs maintain potential to generate derivatives of three germ layers
In addition to hematopoietic specification (representing mesoderm development), SR-bFGF culture conditions sustained hESC capacity to undergo ectoderm and endoderm lineage differentiation. Using quantitative real-time PCR, expression of germ layer specific genes were detected from differentiated EBs generated from hESCs cultured in either MEF-CM or SR-bFGF.
Human EBs generated from either MEF-CM or SR-bFGF cultured hESC lines were capable of differentiating into ectoderm and endoderm, as demonstrated by similar levels of Pax-6 (ectoderm) and HNF3 (endoderm) expression (Fig. 5a, b) .
To further confirm the potential to form derivatives of all three embryonic germ layers and pluripotent differentiation potential of hESCs cultured in SR-bFGF in vivo, we injected SR-bFGFmaintained hESCs into the testis capsules of NOD/SCID mice. All mice receiving hESCs cultured in SR-bFGF produced teratomas (n=5, independent experiments). Testicular growths were palpable four weeks post injection. There was no gross evidence of metastases to other organs or other sites within the peritoneal cavity (not shown). The cut surfaces of the tumors displayed mucinous or serous cysts and solid components. Microscopically, all tumors contained tissues representing all three embryonic germ layers, including ectoderm (cystic epithelium, neural rosettes, and squamous epithelium), mesoderm (bone, muscle, and adipocytes (not shown)), and endoderm (glandular epithelium) (Fig. 5c-h ). These results demonstrate that SR-bFGF-cultured hESCs can be applied not only for studies of hematopoietic specification, but also towards fundamental studies of hESC pluripotency in vivo.
Discussion
We report that high concentrations of bFGF in serum free media are sufficient in sustaining the replicative and differentiative potential of hESCs in the absence of MEFs or MEF-CM. Based on our observations, we suggest that bFGF most likely represents a signaling pathway similar to LIF for murine ESCs. It will be critical to evaluate the specific downstream targets of bFGF in hESCs cultured in these defined conditions, and compare them to potential common targets represented by murine ESCs cultured in the media with serum and LIF alone or in serum-free media with LIF and BMP-4 19 .
Currently, hESCs have been found to be capable of incorporating the non-human sialic acid N-glycolylneuraminic acid (Neu5Gc) 20 . Animal sources of Neu5Gc might cause potential 
